MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Eli Lilly and Co Company Profile (NYSE:LLY)

Consensus Ratings for Eli Lilly and Co (NYSE:LLY) (?)
Ratings Breakdown: 4 Hold Rating(s), 15 Buy Rating(s)
Consensus Rating:Buy (Score: 2.79)
Consensus Price Target: $96.37 (28.68% upside)

Analysts' Ratings History for Eli Lilly and Co (NYSE:LLY)
Show:
DateFirmActionRatingPrice TargetActions
6/26/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016SunTrustReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2016Morgan StanleyReiterated RatingHold$88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Credit SuisseReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2016Jefferies GroupReiterated RatingBuy$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016BMO Capital MarketsLower Price TargetOutperform$95.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Societe GeneraleInitiated CoverageHold$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2016Deutsche BankReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Berenberg BankBoost Price TargetBuy$105.00 -> $106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Goldman SachsLower Price TargetNeutral$88.00 -> $86.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Sanford C. BernsteinLower Price TargetOutperform$93.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/15/2016ArgusReiterated RatingBuy$93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2015Bank of AmericaReiterated RatingBuy$104.00 -> $108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2015Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Citigroup Inc.Lower Price Target$109.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015BarclaysUpgradeEqual Weight -> Overweight$75.00 -> $95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/21/2015JPMorgan Chase & Co.Boost Price TargetNeutral$83.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2015Cowen and CompanyReiterated RatingOutperform$92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Tigress FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2014MKM PartnersBoost Price TargetNeutral$61.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/1/2014S&P Equity ResearchInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Eli Lilly and Co (NYSE:LLY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/26/2016        
4/26/2016Q116$0.85$0.83$4.82 billion$4.87 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$0.78$0.78$5.33 billion$5.38 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2015Q315$0.76$0.89$4.99 billion$4.96 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215$0.74$0.90$4.89 billion$4.98 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115$0.76$0.87$4.62 billion$4.64 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015Q414$0.74$0.75$5.21 billion$5.12 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q314$0.67$0.66$4.83 billion$4.88 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214$0.65$0.68$4.88 billion$4.94 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q114$0.70$0.70$4.78 billion$4.68 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/30/2014Q413$0.72$0.74$5.46 billion$5.81 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313$1.04$1.11$5.76 billion$5.77 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013Q2 2013$1.01$1.16$5.82 billion$5.93 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2013Q1 2013$1.05$1.14$5.66 billion$5.60 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2013Q4 2012$0.82$0.85$5.78 billion$5.96 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$0.82$0.79ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012$0.76$0.83ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.80$0.92ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2012$0.80$0.87ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2011$1.12$1.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2011$1.18$1.18ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2011$1.16$1.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$1.10$1.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Eli Lilly and Co (NYSE:LLY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.80$0.86$0.83
Q2 20162$0.85$0.88$0.87
Q3 20163$0.83$0.96$0.90
Q4 20163$0.94$1.03$0.97
(Data provided by Zacks Investment Research)
Current Dividend Information for Eli Lilly and Co (NYSE:LLY)
Annual Dividend:$2.04
Dividend Yield:2.72%
Payout Ratio:57.14%
Dividend Growth:0.70% (3 Year Average)

Dividend History for Eli Lilly and Co (NYSE:LLY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/20/2016quarterly$0.512.81%8/11/20168/15/20169/9/2016Tweet This Announcement  Share This Announcement on StockTwits
5/2/2016quarterly$0.512.68%5/11/20165/13/20166/10/2016Tweet This Announcement  Share This Announcement on StockTwits
12/8/2015quarterly$0.512.43%2/10/20162/12/20163/10/2016Tweet This Announcement  Share This Announcement on StockTwits
10/19/2015quarterly$0.502.57%11/10/201511/13/201512/10/2015Tweet This Announcement  Share This Announcement on StockTwits
6/15/2015quarterly$0.502.42%8/12/20158/14/20159/10/2015Tweet This Announcement  Share This Announcement on StockTwits
5/4/2015quarterly$0.502.78%5/14/20155/18/20156/10/2015Tweet This Announcement  Share This Announcement on StockTwits
12/15/2014quarterly$0.502.89%2/11/20152/13/20153/10/2015Tweet This Announcement  Share This Announcement on StockTwits
10/20/2014quarterly$0.493.03%11/12/201411/14/201412/10/2014Tweet This Announcement  Share This Announcement on StockTwits
6/16/2014quarterly$0.493.31%8/13/20148/15/20149/10/2014Tweet This Announcement  Share This Announcement on StockTwits
5/5/2014quarterly$0.493.35%5/13/20145/15/20146/10/2014Tweet This Announcement  Share This Announcement on StockTwits
12/16/2013quarterly$0.493.98%2/12/20142/14/20143/10/2014Tweet This Announcement  Share This Announcement on StockTwits
10/21/2013quarterly$0.493.91%11/13/201311/15/201312/10/2013Tweet This Announcement  Share This Announcement on StockTwits
6/18/2013quarterly$0.493.82%8/13/20138/15/20139/10/2013Tweet This Announcement  Share This Announcement on StockTwits
5/6/2013quarterly$0.493.62%5/14/20135/16/20136/10/2013Tweet This Announcement  Share This Announcement on StockTwits
12/17/2012quarterly$0.493.96%2/13/20132/15/20133/8/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Eli Lilly and Co (NYSE:LLY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/10/2016Melissa S BarnesSVPSell992$73.77$73,179.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2016Lilly Endowment IncMajor ShareholderSell200,000$75.12$15,024,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Jackson P TaiDirectorBuy1,080$75.75$81,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Lilly Endowment IncMajor ShareholderSell190,000$75.86$14,413,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Donald A ZakrowskiCAOSell1,600$75.86$121,376.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2016Lilly Endowment IncMajor ShareholderSell180,000$75.44$13,579,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Alfonso G ZuluetaSVPSell12,000$76.27$915,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2016Lilly Endowment IncMajor ShareholderSell200,000$74.29$14,858,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Stephen F FrySVPSell15,230$78.87$1,201,190.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016David A. RicksSVPSell5,733$77.66$445,224.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Derica W. RiceCFOSell10,483$77.78$815,367.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Jackson P TaiDirectorBuy3,170$78.62$249,225.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/29/2016Alfonso G ZuluetaSVPSell5,000$78.75$393,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Lilly Endowment IncMajor ShareholderSell205,000$86.00$17,630,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2015Lilly Endowment IncMajor ShareholderSell215,000$85.60$18,404,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Enrique A ConternoVPSell25,000$83.88$2,097,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Lilly Endowment Incmajor shareholderSell210,000$85.09$17,868,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Lilly Endowment Incmajor shareholderSell205,000$84.54$17,330,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Lilly Endowment Incmajor shareholderSell200,000$82.28$16,456,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2015Lilly Endowment Incmajor shareholderSell215,000$85.86$18,459,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/5/2015Lilly Endowment Incmajor shareholderSell260,000$86.46$22,479,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2015Lilly Endowment Incmajor shareholderSell250,000$89.04$22,260,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Lilly Endowment IncMajor ShareholderSell210,000$82.39$17,301,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Lilly Endowment IncMajor ShareholderSell200,000$77.90$15,580,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Jeffrey N SimmonsSVPSell20,000$78.08$1,561,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2015Lilly Endowment IncMajor ShareholderSell190,000$73.43$13,951,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Lilly Endowment IncMajor ShareholderSell200,000$72.83$14,566,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2015Lilly Endowment IncMajor ShareholderSell195,000$73.28$14,289,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2015Lilly Endowment IncMajor ShareholderSell200,000$73.09$14,618,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Lilly Endowment IncMajor ShareholderSell180,000$73.94$13,309,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/23/2015Lilly Endowment IncMajor ShareholderSell190,000$76.97$14,624,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Stephen F FrySVPSell4,000$69.27$277,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015David A RicksSVPSell3,147$69.99$220,258.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Derica W RiceCFOSell5,316$70.00$372,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Jan M LundbergEVPSell11,085$70.08$776,836.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Jan M LundbergEVPSell121,711$70.78$8,614,704.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015David A RicksSVPSell4,769$71.51$341,031.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Derica W RiceCFOSell10,068$71.84$723,285.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2014Lilly Endowment IncMajor ShareholderSell190,000$71.92$13,664,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Lilly Endowment IncMajor ShareholderSell180,000$70.14$12,625,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Lilly Endowment IncMajor ShareholderSell200,000$67.73$13,546,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2014Lilly Endowment IncMajor ShareholderSell180,000$67.00$12,060,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014Fionnuala M WalshSVPSell15,000$67.00$1,005,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Enrique A ConternoVPSell5,000$66.03$330,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Fionnuala M WalshSVPSell7,376$66.58$491,094.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Lilly Endowment IncMajor ShareholderSell190,000$66.40$12,616,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Lilly Endowment IncMajor ShareholderSell175,000$66.58$11,651,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Maria A CroweInsiderSell2,750$65.77$180,867.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014Lilly Endowment IncMajor ShareholderSell210,000$65.63$13,782,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Enrique A ConternoVPSell5,000$64.86$324,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Lilly Endowment IncMajor ShareholderSell200,000$65.07$13,014,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Lilly Endowment IncMajor ShareholderSell210,000$64.77$13,601,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2014Lilly Endowment IncMajor ShareholderSell200,000$63.99$12,798,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/2/2014Enrique A ConternoVPSell5,000$63.60$318,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2014Lilly Endowment IncMajor ShareholderSell250,000$63.03$15,757,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2014Susan MahonySVPSell2,065$63.30$130,714.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Enrique A ConternoVPSell10,000$63.79$637,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Susan MahonySVPSell30,000$63.90$1,917,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Lilly Endowment IncMajor ShareholderSell235,000$62.30$14,640,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/25/2014Lilly Endowment IncMajor ShareholderSell245,000$62.68$15,356,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2014Lilly Endowment IncMajor ShareholderSell230,000$61.55$14,156,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Lilly Endowment IncMajor ShareholderSell200,000$58.73$11,746,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Lilly Endowment IncMajor ShareholderSell190,000$59.53$11,310,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2014Lilly Endowment Incmajor shareholderSell230,000$58.90$13,547,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Jackson TaiDirectorBuy17,157$59.19$1,015,522.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Lilly Endowment Incmajor shareholderSell210,000$59.33$12,459,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2014Lilly Endowment Incmajor shareholderSell190,000$58.79$11,170,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014Lilly Endowment Incmajor shareholderSell200,000$59.43$11,886,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2014Lilly Endowment Incmajor shareholderSell150,000$58.64$8,796,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Enrique ConternoVPSell5,000$53.79$268,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Jacques TapieroSVPSell7,500$53.74$403,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Enrique A ConternoVPSell5,000$51.43$257,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2013Enrique A ConternoVPSell5,000$52.45$262,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Enrique A ConternoVPSell5,000$56.15$280,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013Jeffrey N SimmonsSVPSell10,000$54.49$544,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2013Susan MahonySVPSell5,000$56.00$280,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Eli Lilly and Co (NYSE:LLY)
DateHeadline
06/27/16 04:54 PMWorth Watching Stocks on the Move: Eli Lilly and Co (NYSE:LLY), Mosaic Co (NYSE:MOS) - NYSE Journal (press release)
06/27/16 04:54 PMAnalysts Observing Stocks: Horizon Pharma plc (NASDAQ:HZNP) , Eli Lilly and Company (NYSE:LLY) - Street Updates
06/27/16 04:54 PMEli Lilly & Co (NYSE:LLY) Declared Third Quarter Dividend - Street Report
06/27/16 03:27 PMA Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle -
06/27/16 02:21 PMLilly Convenes Leaders at National Mayor's Conference to Address Impact of Alzheimer's Disease on Local Communities - [at noodls] - INDIANAPOLIS, June 27, 2016 /PRNewswire/ -- With the prevalence of Alzheimer's disease expected to triple by 2050, there is an urgent need for greater awareness of the economic and social impact of the ...
06/27/16 09:19 AMThe Implications of the ‘Brexit’ Vote, Stress Tests and Puerto Rico
06/27/16 09:19 AMHarvard Pilgrim adds new drugs under ‘pay-for-performance’ deals
06/26/16 11:01 PMAfter 190 Tries, Are We Any Closer to a Cure for Alzheimer’s? -
06/26/16 09:40 AMEli Lilly : Best friends team up to develop new drug
06/25/16 04:36 PMMedtronic PLC (NYSE:MDT) & Eli Lilly and Co (NYSE:LLY) Healthcare Active Movers - Wall Street 24
06/24/16 07:36 AMPatients with psoriasis treated with Taltz reported improvements in work productivity
06/24/16 07:36 AMEli Lilly : New Study Findings Underscore Importance of Physician/Patient Communication on Insulin Adherence and Outcomes
06/24/16 07:32 AMU.S. FDA panel to vote whether diabetes drug cuts cardiac death - [Reuters - UK Focus] - An advisory panel to the U.S. Food and Drug Administration will be asked to vote next week on whether a diabetes drug made by Eli Lilly & Co and Boehringer Ingelheim cuts the risk of cardiovascular death, ...
06/23/16 05:23 PMWorth Watching Stock's News Analysis Report: Eli Lilly and Co (NYSE:LLY), Cenovus Energy Inc (NYSE:CVE) - NYSE Journal (press release)
06/23/16 05:23 PMStock's Buzzers: Stone Energy Corporation (NYSE:SGY), Eli Lilly and Co (NYSE:LLY) - NYSE Journal (press release)
06/23/16 05:23 PMHC Stocks Alerts: Anthem Inc (NYSE:ANTM), Eli Lilly and Co (NYSE:LLY) - share market updates (press release)
06/23/16 05:23 PMEli Lilly and Co (NYSE:LLY) Sees No Pricing Pressure On Newer Drugs - Market Exclusive
06/23/16 10:56 AMEli Lilly : Diabetes Scholars Foundation Announces 2016 Scholarship Recipients
06/23/16 09:39 AMDiabetes Scholars Foundation Announces 2016 Scholarship Recipients - [at noodls] - PARK RIDGE, Ill. and INDIANAPOLIS, June 23, 2016 /PRNewswire/ -- If the caliber of students receiving a Lilly Diabetes Tomorrow's Leaders Scholarship is any indication, the future is in good hands. The ...
06/22/16 03:02 PMMacroStat Receives 2016 Lilly Global Supplier Award
06/22/16 02:37 PMHow Big Is the Diabetes Treatment Market? -
06/21/16 09:28 AMShares Trading down at $73.82 Lilly Declares Third-Quarter 2016…
06/21/16 09:28 AMStock Update: Eli Lilly & Company (NYSE:LLY) – Lilly Declares Third-Quarter 2016 Dividend
06/21/16 09:28 AMEli Lilly and Co (NYSE:LLY) Sees No Pricing Pressure On Newer Drugs
06/20/16 04:49 PMNotable Traders Watch list: Sprint Corp (NYSE:S), Eli Lilly and Co (NYSE:LLY) - NYSE Journal (press release)
06/20/16 12:59 PMLilly Declares Third-Quarter 2016 Dividend - [at noodls] - INDIANAPOLIS, June 20, 2016 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2016 of $0.51 per share on outstanding common stock. ...
06/20/16 12:03 PMThis New Class Of Medicine Could Reshape Diabetes Treatment - Based on a trial of Eli Lilly's SGLT-2 inhibitor, Jardiance, the treatment may significantly reduce heart attacks and strokes for diabetes patients. But it's by no means assured that Lilly will be the big beneficiary of the news.
06/19/16 09:03 AMEli Lilly : In Alimta patent lawsuit, SC of Germany grants Eli Lilly petition
06/17/16 04:50 PMEli Lilly and Co (NYSE:LLY) & Pernix Therapeutics Holdings (NASDAQ:PTX) Trending Healthcare Stocks - Wall Street 24
06/16/16 05:06 PMEli Lilly and Co: New Drugs to Drive Turnaround Growth - Bidness ETC
06/16/16 09:15 AMChina's supreme court rules against Eli Lilly in patent infringement case
06/16/16 09:15 AMSupreme Court in Germany Rules on Lilly Infringement Case
06/16/16 07:10 AMElanco Opens State-of-the-Art Vaccines Innovation Center - [PR Newswire] - GREENFIELD, Ind., June 16, 2016 /PRNewswire/ -- Today Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), announces the opening of a state-of-the-art Vaccines Innovation Center whose ...
06/16/16 07:00 AMElanco, EnBiotix Establish Collaboration Exploring Engineered Phage Technology - [Business Wire] - Today Elanco Animal Health, a division of Eli Lilly and Company, and EnBiotix, Inc., announced a collaboration to explore the application of EnBiotix’s engineered phage technology in specific animal health targets.
06/15/16 04:57 PMWorth Watching Stocks Under Consideration: Eli Lilly and Co (NYSE:LLY), Terra Form Power Inc (NASDAQ:TERP) - NYSE Journal (press release)
06/15/16 04:57 PMAmgen, Inc. (NASDAQ:AMGN) & Eli Lilly and Co (NYSE:LLY) Stocks Alert - Wall Street 24
06/15/16 04:57 PMEli Lilly and Co (NYSE:LLY) & Minerva Neurosciences (NASDAQ:NERV) Stocks in Focus - Wall Street 24
06/15/16 04:57 PMEli Lilly and Co. Names CIO - Inside INdiana Business
06/15/16 04:57 PMBRIEF-Eli Lilly and Co says German supreme court grants Lilly appeal in Alimta vitamin regimen patent lawsuit - Reuters
06/15/16 12:19 PMBetter Buy: Johnson & Johnson vs. Eli Lilly - It's a showdown between the healthcare conglomerate and the diabetes pioneer.
06/15/16 09:35 AMEli Lilly : German Supreme Court Grants Lilly Appeal in Alimta® Vitamin Regimen Patent Lawsuit
06/14/16 06:37 PMBRIEF-Eli Lilly and Co says German supreme court grants Lilly appeal in Alimta vitamin regimen patent lawsuit - * Eli lilly and co says german supreme court grants lilly appeal in alimta vitamin regimen patent lawsuit
06/14/16 05:59 PMGerman Supreme Court Grants Lilly Appeal in Alimta® Vitamin Regimen Patent Lawsuit - [at noodls] - INDIANAPOLIS, June 14, 2016 /PRNewswire/ -- The German Federal Supreme Court has granted the appeal by Eli Lilly and Company (NYSE: LLY) in the case of Eli Lilly and Company v. Actavis, vacating the prior ...
06/14/16 04:45 PMLilly's Jardiance slows kidney disease progression in diabetics
06/14/16 04:45 PMEli Lilly and Co. Names CIO
06/14/16 09:45 AMShah Promoted to CIO at Lilly
06/14/16 09:45 AMCompany Update: Eli Lilly & Company (NYSE:LLY) – Novo diabetes drug cuts heart risks by 13 pct in key trial
06/14/16 08:17 AMNovo Nordisk Drug Cuts Diabetic Deaths, But Not Enough For Wall Street -
06/14/16 07:25 AMThe Morning Download: CIOs Cite Benefits of an Integrated Microsoft, LinkedIn Experience - [at The Wall Street Journal] - The acquisition “speaks to how social media tools are becoming mainstream in the enterprise and how employees conduct business every day,” said Steve Phillips, CIO at Avnet Inc.
06/14/16 01:43 AMNovo diabetes drug cuts heart risks by 13 pct in trial - [Reuters] - Novo Nordisk's top-selling diabetes drug Victoza cut the risk of heart attack, stroke and cardiovascular death by 13 percent in a closely watched study that may encourage wider use of the blockbuster injectable medicine. Victoza is only the second diabetes drug to show such heart benefits, after Eli Lilly and Boehringer Ingelheim's pill Jardiance. "To me, the impressive thing about this trial is the consistency across clinical endpoints and its robustness," said John Buse, professor of medicine at the UNC School of Medicine, who worked on the study.
About Eli Lilly and Co

Eli Lilly and Co logoEli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment operates through the Company's Elanco division, which develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, such as Humalog and Humalog Mix 75/25; neuroscience products, such as Cymbalta and Zyprexa; oncology products, such as Alimta and Cyramza, and cardiovascular products, such as Cialis and ReoPro. The Company's animal health products segment includes products for food animals, such as Rumensin and Posilac; products for companion animals, such as Onsior and Osurnia, and Novartis Animal Health (Novartis AH) products.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: LLY
  • CUSIP: 53245710
Key Metrics:
  • Previous Close: $74.89
  • 50 Day Moving Average: $74.87
  • 200 Day Moving Average: $76.66
  • P/E Ratio: 34.51
  • P/E Growth: 1.67
  • Market Cap: $79.38B
  • Current Quarter EPS Consensus Estimate: $3.57 EPS
Additional Links:
Eli Lilly and Co (NYSE:LLY) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha